James Andrea S. 4
4 · Oncocyte Corp · Filed Mar 28, 2025
Insider Transaction Report
Form 4
James Andrea S.
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2025-03-26+113,207→ 113,207 totalExercise: $0.00→ Common Stock (113,207 underlying)
Footnotes (1)
- [F1]25% of the restricted stock units will vest on each of the one-, two-, three- and four-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date.